|This article relies too much on references to primary sources. (December 2006)|
|Type||Public company (ASX:SIP)|
|Founded||1912 in Melbourne, Australia|
|Headquarters||Rowville, Victoria, Australia|
|Key people||Brian Jamieson (Chairman)
Mark Hooper (CEO & managing director)
|Products||Prescription, Over-the-counter and Generic Pharmaceutical Products|
|Net income||A$53.5 million|
Central Healthcare Services
Discount Drug Store (DDS)
Sigma Pharmaceuticals Limited is a full line wholesale and distribution business to pharmacy. It is also the owner of Australia's best known pharmacy retail brands: Amcal Max, DDS, Amcal and Guardian.
Sigma restructured in 2010, disposing of its generic drug manufacturing business.
The company's sales revenue grew 1.1 percent to $3 billion in 2013-14, while net profit climbed 187 percent to $53.5 million.
Mergers & acquisitions
In March 2014, Sigma acquired Central Healthcare Services, in a deal worth $24.5 million. In September 2014, the company bought the Queensland-based Discount Drug Store (DDS) banner for $26.7 million. The DDS acquisition was set to add 120 pharmacies under that brand to the Sigma network.
2010 trading halt
In 2010, Sigma shares were placed in a trading halt on the Australian Stock Exchange – initially due to a profit warning. Since then, allegations of accounting irregularities and preferential deals negotiated with certain pharmacy chains (at the expense of smaller independent chemists) that left Sigma losing money at the expense of their own Amcal and Guardian Pharmacies banners and forsaking cashflow emerged. The trading halt was lifted later that year. The events resulted in the initiation of a shareholder class action before the Federal Court of Australia.
- "Sigma extends retail brands with DDS acquisition for $26.7 mn". Sydney Sun. 8 September 2014. Retrieved 8 September 2014.
- Subdued Seven eyes licence fee rebates
- Cookies must be enabled | The Australian
- Picture looks bleak for Telstra